ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 Nuclear Energy Conference & Expo (NECX)
August 24–27, 2026
Dallas, TX|Hilton Anatole
Latest Magazine Issues
Jun 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
July 2026
Nuclear Technology
June 2026
Fusion Science and Technology
May 2026
Latest News
North American construction is back—smaller and faster—at OPG’s Darlington
“The nuclear renaissance is real here,” said Ontario Power Generation’s Subo Sinnathamby on May 8, one year to the day after OPG secured a final investment decision to build the first of four planned BWRX-300 reactors at its Darlington nuclear power plant, and shortly after the new reactor’s foundation was lifted into place. “We got our license to construct in April and our [final investment decision] in May, and we’ve been off to the races since.”
Sakae Kinase, Shinpei Matsuhashi, Kimiaki Saito
Nuclear Technology | Volume 168 | Number 1 | October 2009 | Pages 154-157
Dose/Dose Rate | Special Issue on the 11th International Conference on Radiation Shielding and the 15th Topical Meeting of the Radiation Protection and Shielding Division (Part 1) / Radiation Protection | doi.org/10.13182/NT09-A9117
Articles are hosted by Taylor and Francis Online.
Knowledge of interspecies scaling of organ doses from experimental animals such as mice to humans is important in the preclinical evaluation of new radiopharmaceuticals. Interspecies scaling factors should be reliably determined since the dose-response relationships in mice would be translated to those in humans. To obtain reliable interspecies scaling factors of organ doses from mice to humans, absorbed fractions (AFs) are needed for sophisticated models on both mice and humans. In the present study, self-AFs for photons and electrons in the spleen, kidneys, and liver of both a mouse and humans were evaluated using Monte Carlo simulations. For the mouse and human models, voxel phantoms based on computed tomography were used. The sources were assumed to be monoenergetic in the energy range 10 keV to 4 MeV and to be uniformly distributed in the spleen, kidneys, and liver. Interspecies scaling factors were determined using the results of the self-AFs for the voxel mouse and voxel human. Consequently, interspecies scaling factors were found to be dependent upon energy emitted in the source organ. It was found that the scaling factor for the photon self-AF, which is corrected by the cube root of the organ mass, shows a similar trend as a function of energy with the scaling factor for the electron self-AF.